Choreo LLC trimmed its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 20.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,894 shares of the conglomerate’s stock after selling 3,742 shares during the quarter. Choreo LLC’s holdings in Danaher were worth $2,958,000 at the end of the most recent reporting period.
A number of other hedge funds have also made changes to their positions in the company. WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter valued at approximately $26,000. Howard Hughes Medical Institute purchased a new stake in Danaher in the 2nd quarter valued at approximately $27,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher during the 3rd quarter valued at $27,000. TruNorth Capital Management LLC acquired a new stake in Danaher during the 3rd quarter valued at $28,000. Finally, Tripletail Wealth Management LLC purchased a new position in Danaher during the third quarter worth $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Wall Street Analysts Forecast Growth
DHR has been the topic of several recent research reports. Wells Fargo & Company upped their price objective on Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. JPMorgan Chase & Co. boosted their target price on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research note on Thursday, January 29th. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. HSBC lifted their price target on shares of Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a report on Monday, December 1st. Finally, Robert W. Baird set a $251.00 price objective on shares of Danaher in a research note on Thursday, January 29th. Twenty investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $253.86.
Insiders Place Their Bets
In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.
Danaher Trading Up 0.4%
Shares of DHR stock opened at $210.28 on Friday. The firm’s 50-day simple moving average is $225.33 and its 200-day simple moving average is $216.23. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80. The firm has a market cap of $148.70 billion, a P/E ratio of 41.72, a PEG ratio of 2.85 and a beta of 0.91.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, topping the consensus estimate of $2.14 by $0.09. The firm had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. Danaher’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.14 earnings per share. As a group, equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.
Danaher Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a $0.40 dividend. This is an increase from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date of this dividend is Friday, March 27th. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. Danaher’s dividend payout ratio is 25.40%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
